Linde | LIN - Sales Revenues

Stock Price
436.60
Daily Change
-0.40 -0.09%
Monthly
3.12%
Yearly
7.06%
Q2 Forecast
425.64

Linde reported $8.76B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Air Products & Chemicals USD 3.2B 100M Mar/2026
Acerinox EUR 1.38B 70M Mar/2026
Air Liquide EUR 6.79B 6.43B Mar/2026
Akzo Nobel EUR 2.39B 20M Mar/2026
Arkema EUR 2.18B 70M Mar/2026
BASF EUR 16.02B 1.99B Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Corteva USD 4.73B 820M Mar/2026
Covestro EUR 2.92B 255M Dec/2025
Dow USD 9.8B 340M Mar/2026
Dupont De Nemours USD 1.68B 20M Mar/2026
Henkel EUR 10.09B 4.93B Dec/2025
Huntsman USD 1.42B 60M Mar/2026
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Linde USD 8.76B 149M Dec/2025
LyondellBasell Industries USD 7.2B 110M Mar/2026
Merck EUR 5.13B 120M Mar/2026
PPG Industries USD 3.86B 50M Mar/2026
Sherwin-Williams USD 5.67B 70M Mar/2026
Sika AG CHF 5.52B 151.5M Dec/2025
Solvay EUR 997M 2M Mar/2026
Umicore EUR 10.68B 8.89B Dec/2025
Westlake Chemical USD 2.65B 120M Mar/2026